Key result
Hybrid coronary revascularization shows similar midterm MACCE rates compared to off-pump CABG.
Why the study?
Hybrid coronary revascularization has been shown safe and effective in selected multivessel coronary artery disease patients, but inclusion criteria are too strict.
Does generalized hybrid coronary revascularization reduce major adverse cardiac or cerebrovascular events compared to conventional off-pump coronary artery bypass grafting in patients with multivessel coronary artery disease?
Cohort (n=222)
Does generalized hybrid coronary revascularization reduce major adverse cardiac or cerebrovascular events compared to conventional off-pump coronary artery bypass grafting in patients with multivessel coronary artery disease?
Hazard Ratio: 0.567 (95% CI 0.268–1.201)
Absolute Event Rate: 9.9% vs 16.2%
p-value: p=0.138
Generalized hybrid coronary revascularization provides similar midterm MACCE outcomes to conventional off-pump CABG, with the benefit of lower IABP implantation rates and shorter postoperative length of stay.
Supports evaluation of generalized HCR in multivessel disease; leaves open need for randomized trials before clinical adoption.
Background Hybrid coronary revascularization (HCR) has been demonstrated as a safe and effective revascularization strategy in selected patients with multivessel coronary artery disease; however, the inclusion criteria are too strict. Objectives This study was conducted to compare in-hospital and midterm outcomes after generalized HCR and off-pump coronary artery bypass (OPCABG) in patients with multivessel coronary artery disease. Methods We proposed a generalized idea of HCR. First, the PCI for non-LAD vessels suitable for coronary stents was performed. Then, MICS-CABG for LIMA to the LAD and saphenous to other non-LAD vessels that were not suitable for stents or stenting failed. Propensity score matching was used, and 222 patients (n = 111 in both the generalized HCR and OPCABG groups) were enrolled in the study. The primary endpoint was a major adverse cardiac or cerebrovascular event (MACCE) over midterm follow-up, and the secondary endpoints were in-hospital outcomes. Results No significant difference was observed in the cumulative rate of MACCE (9.9% vs. 16.2%; HR, 0.567; 95% CL, 0.268–1.201; P = 0.138) between the generalized HCR and OPCABG groups. The residual SYNTAX score was similar between two groups (6.3 ± 5.5 for generalized HCR vs. 6.8 ± 5.3 for OPCABG; P = 0.486). Compared with OPCABG, generalized HCR was associated with a significantly lower intra-aortic balloon pump (IABP) implantation rate (2.7% vs. 9.9%; P = 0.027) and shorter postoperative length of stay (6.3 ± 3.2 vs. 7.7 ± 3.0; P = 0.001). Conclusions The generalized HCR procedure appears to be safe and efficacious, with outcomes similar to those of standard off-pump CABG and satisfactory completeness of revascularization.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) conducted a cohort in Multivessel coronary artery disease (n=222). Generalized hybrid coronary revascularization vs. Conventional off-pump coronary artery bypass grafting (OPCABG) was evaluated on Major adverse cardiac or cerebrovascular event (MACCE) (HR 0.567, 95% CI 0.268-1.201, p=0.138). Generalized hybrid coronary revascularization resulted in a similar rate of midterm MACCE compared to conventional off-pump CABG (9.9% vs. 16.2%; HR 0.567; 95% CI 0.268-1.201; P=0.138).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: